Loading

NORML Blog

  • by Paul Armentano, NORML Deputy Director February 1, 2012

    [Editor's note: This post is excerpted from this week's forthcoming NORML weekly media advisory. To have NORML's news alerts and legislative advisories delivered straight to your in-box, sign up here.]

    Some two-thirds of Israeli cancer patients authorized to use cannabis report long-term, symptomatic improvement from the plant, according to clinical data presented in late January at a conference of the Israeli Oncologists Union and reported this week in several international media outlets.

    Investigators at the Sheba Medical Center in Tel Aviv, in conjunction with the Israeli Cancer Association, assessed the efficacy of cannabis therapy over the course of one year in 264 patients with cancer. Israeli media reported the findings:

    Some 61 percent of the respondents reported a significant improvement in their quality of life as a result of the medical marijuana, while 56 percent noted an improvement in their ability to manage pain. In general, 67 percent were in favor of the treatment, while 65 percent said they would recommend it to other patients.”

    The study concluded that cannabis is an “effective” treatment for certain symptoms of the disease cancer and recommended, “The treatment should be offered to the patients in earlier stages of cancer.”

    In the trial, the most common types of cancer for which medical marijuana was authorized was lung cancer (21 percent ), breast cancer (12 percent ) and pancreatic cancer (10 percent ).

    The study focused primarily on the use of cannabis to relieve various symptoms of cancer or cancer treatment, such as pain and nausea, but did not evaluate whether marijuana therapy could potentially suppress the proliferation of the disease. In preclinical trials, various cannabinoids – including THC and CBD (cannabidiol) – have been shown to selectively target and eliminate malignant cells and cancerous tumors.

    To date, some 6,000 Israelis possess government authorization to use cannabis therapeutically. Patients authorized by the federal program may either cultivate cannabis at home or they may obtain marijuana from one of the nation’s 12 licensed cannabis farms.

    Last summer, the Israeli Health Ministry formally acknowledged the therapeutic utility of cannabis and announced newly amended guidelines to more effectively govern the state-sponsored production and distribution of medical marijuana. The Ministry estimates that as many as 40,000 patients will eventually have access to medicinal cannabis once the Israeli program is fully implemented.

    NORML’s literature review of the anti-cancer properties of cannabis and cannabinoids is available here.

  • by Erik Altieri, NORML Communications Coordinator January 31, 2012

    Last night, President Obama took to Google+ and responded to the questions submitted to him from the general public. Despite accounting for a majority of the top questions, the moderator never asked Obama about marijuana legalization and the president certainly didn’t volunteer any comment of his own volition.

    It is immensely disappointing that, yet again, the administration has declined the opportunity to discuss the very serious issue of ending marijuana prohibition in this country. For the ninth time, the White House has solicited the American people for direct input on the issues they cared about, and then, when the resulting answers called overwhelmingly for marijuana law reform, President Obama ignored the will of the American. Over half of the country now supports regulating and taxing marijuana; we can only hope that during the general election the issue is addressed with the respect and urgency it demands. (Alternet)

    You can read more details here.

  • by Paul Armentano, NORML Deputy Director

    January 2012 marks the beginning of a new legislative session in all 50 states. Already, marijuana law reform legislation is pending (or has been pre-filed) in over a dozen states. To keep up to date with what’s pending, and how you can support marijuana-friendly reform measures in your state, please visit NORML’s ‘Take Action Center’ here.

    You can also stay abreast of 2012 statewide ballot initiative efforts, such as those ongoing in Colorado and elsewhere, via NORML’s Legalize 2012 Facebook page here.

    Below is this week’s edition of NORML’s Weekly Legislative Round Up — where we spotlight specific examples of pending marijuana law reform legislation from around the country.

    ** A note to first time readers: NORML can not introduce legislation in your state. Nor can any other non-profit advocacy organization. Only your state representatives, or in some cases an individual constituent (by way of their representative; this is known as introducing legislation ‘by request’) can do so. NORML can — and does — work closely with like-minded politicians and citizens to reform marijuana laws, and lobbies on behalf of these efforts. But ultimately the most effective way — and the only way — to successfully achieve statewide marijuana law reform is for local stakeholders and citizens to become involved in the political process and to make the changes they want to see. Get active; get NORML!

    ALABAMA: The Michael Phillips Compassionate Care Act (HB 25) which seeks to enact legal protections for authorized medical marijuana patients, has been marked for reintroduction in the Alabama Legislature for the session starting on February 7th. It is currently assigned to the House Committee on Health. A separate medical cannabis bill, House Bill 66, has also been prefiled in the House and is also before to the House Committee on Health, while a third measure that seeks to reduce penalties on adult cannabis possession is anticipated to be introduced shortly. You can learn more about these efforts via NORML’s ‘Take Action Center’ here.

    INDIANA: Senate lawmakers heard testimony on Tuesday, January 24, in favor of legislation, SB 347, to decriminalize marijuana possession penalties in Indiana. Lawmakers on Senate Committee on Corrections, Criminal, and Civil Matters did not vote on the measure. Therefore, there is still time for constituents to contact their Senate members and encourage them to support marijuana law reform. You can do so via NORML’s ‘Take Action Center’ here. A separate House measure, HB 1370, that seeks to legalize the use of cannabis for medicinal purposes, is pending before the House Committee on Public Policy.

    KANSAS: House Bill 2330, which seeks to enact legal protections for authorized medical marijuana patients, was heard by the House Committee on Health and Human Services on Tuesday, January 24th. You can read media coverage of the hearing here and here. You can track the progress of this measure and contact your state elected officials regarding HB 2330 here.

    NEW HAMPSHIRE: Members of the House Criminal Justice Committee heard testimony on Thursday, January 25, in favor of House Bill 1705, which seeks to allow adults age 21 or over to use marijuana legally in their home. The measure also seeks to establish a regulated cannabis market governing the wholesale production and sale of marijuana. Non-commercial transactions involving less than one ounce of cannabis would not be subject to state taxation or regulation under the measure. You can watch clips from the hearing here and you can contact your elected officials in support of the measure here.

    The House Criminal Justice Committee is also scheduled to hear testimony this Thursday in favor of separate legislation, HB 1526, which seeks reduce the penalties on minor marijuana possession offenses (up to one ounce) from a criminal misdemeanor punishable by up to one year in jail and a $2,000 fine to a nominal monetary penalty of no more than $100.00. To contact your House representative regarding HB 1526, please visit NORML’s ‘Take Action Center’ here.

    VIRGINIA: Legislation seeking to establish a joint study committee to investigate the fiscal impact of regulating the production and sale of marijuana to adults 21 and over is anticipated to be heard by the Virginia House Committee on Rules as soon as this Thursday. You can read NORML’s published op/eds in support of this measure here and here. To learn more about House Joint Resolution 140, please visit Virginia NORML or contact your state officials here.

  • by Erik Altieri, NORML Communications Coordinator January 29, 2012

    Last week, the White House launched the next in its long line of social media engagement initiatives, this one entitled “Your Interview With the President.” The concept was simple, anyone could upload their question to the President on YouTube, others would vote on them, and the highest rated ones would be posed to the Commander in Chief in a Google+ Hangout on January 30th.

    This seemed to be a logical opportunity to ask the administration about marijuana legalization. Last Tuesday, I posted NORML’s question to the White House YouTube page for consideration. We asked, “With over 850,000 Americans arrested in 2010, on marijuana charges alone, and tens of billions of tax dollars being spent locking up marijuana users, isn’t it time to regulate and tax marijuana?”

    The reception was overwhelmingly positive, in just several hours the question received over 4,000 “thumbs up” votes and was one of, if not the, most popular question on the service. Then a peculiar thing happened, the question was removed. After becoming the most positively voted upon question in less than a day, the White House removed the question, deeming it “inappropriate.”

    We informed our audience of the censorship and encouraged them to engage the White House on their own, using our question or a one of their own choosing. Over the next several days the program was inundated with marijuana law reform questions. At first, many met the same fate as our original question and were removed from the site. It seems our persistence ended up paying off and the page administrator finally gave up trying to censor the incoming questions and most marijuana inquiries have remained up since.

    Voting closed last night at midnight and I made some rough calculations of the final results to see how we performed. Of the top 160 questions asked, marijuana reform questions accounted for 105 of them. Reposts of our question brought in an estimated 17,524 up-votes in addition to the 4,028 the original received before being removed. Combined, that is over 21,000 votes for one question, which is 5 times as many votes as any other question on the page. The 105 marijuana reform questions in the top 160 brought in over 74,000 votes, dwarfing any other topic. Our friends at LEAP posted a question as well and it ended as one of the top rated questions. You can read their coverage here.

    Now, we wait. “Your Interview With the President” is scheduled to take place tomorrow, January 30th. Considering this is the same individual who previously stated that, “we need to rethink and decriminalize our marijuana laws” and that legalization is a “perfectly legitimate topic for debate,” maybe he will take this opportunity to address the issue seriously for once. In an election year, this could go a long way towards winning back those who feel disenfranchised with the administration over a perceived lack of progress on the issue and amped up raids on medical programs in states such as California and Colorado.

    The American people are ready for our debate Mr. President, are you?

     

  • by Allen St. Pierre, NORML Executive Director

    Today @ 1:30 PM (eastern) the NORML and High Times-sponsored Silver Tour, hosted by America’s longest serving cannabis prisoner Robert Platshorn, is live from Temple Shaarei Shalom in Boynton Beach, Florida.

    Topic of the day: Teaching senior citizens about the safety, utility, effectiveness, cost savings and politics of medical cannabis.

    Featured speakers include Irvin Rosenfeld (one of the five federal medical cannabis patients who receive 300 pre-rolled ‘joints’ monthly from a special and closed-to-the-public medical cannabis research project) and former NORML board member and longtime cannabis medical researcher Mary Lynn Mathre, RN (from Patients Out of Time) and NORML Legal Committee member attorney Michael Minardi.

Page 2 of 19612345...102030...Last »